Home › NDC Lookup › Ingredients › Isopropyl Alcohol › 61333-0222-02
LIGHTS Antiseptic and Pain Relieving Prep Pad ISOPROPYL ALCOHOL 15 g/100mL; 1 g/100mL; 71 g/100mL Solution, 100 patches — NDC 61333-0222-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

LIGHTS Antiseptic and Pain Relieving Prep Pad ISOPROPYL ALCOHOL 15 g/100mL; 1 g/100mL; 71 g/100mL Solution, 100 patches — NDC 61333-222-02 (Billing 61333-0222-02)

by Lights Medical Manufacture Co., Ltd. · 100 POUCH in 1 BOX / 1 PATCH in 1 POUCH / .35 mL in 1 PATCH

This is a package of 100 patches of LIGHTS Antiseptic and Pain Relieving Prep Pad ISOPROPYL ALCOHOL 15 g/100mL; 1 g/100mL; 71 g/100mL Solution from Lights Medical Manufacture Co., Ltd., marketed since Aug 2026 and currently FDA-listed. It is this product's only package size.

NDC 61333-0222-02
🏷️ FDA NDC (as labeled) 61333-222-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 61333-222-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
61333 labeler · 222 product · 02 package
Package marketed since
Aug 7, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 6133322202 7
FDA record last changed
Aug 27, 2026
⚠️
Other active recalls for Isopropyl Alcohol (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 20, 2026 — CGMP Deviations (ACME UNITED CORPORATION) · FDA recall D-0373-2026
Class II · Jul 7, 2025 — Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0604-2025
Class II · Jul 7, 2025 — Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0601-2025
Class II · Jul 7, 2025 — Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0602-2025
Class II · Jul 7, 2025 — Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0600-2025
Class II · Jul 7, 2025 — Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0605-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 61333-222-02
Product NDC 61333-222
11-digit billing NDC 61333022202
RxCUI 2667820
UNII U3RSY48JW5, L7T10EIP3A, ND2M416302
Application # M003
SPL Set ID 91cc7334-f610-487d-a895-3dda78c3372e
Established class (EPC) Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity
Chemical class Allergens
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-08-07
Route TOPICAL
Dosage form SOLUTION
Substance BENZOCAINE; MENTHOL; ISOPROPYL ALCOHOL
Quick answers
  • RxCUI (RxNorm): 2667820
Why two NDCs? The FDA registers this code as 61333-222-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 61333-0222-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Standardized Chemical Allergen class.

Pharmacologic class Standardized Chemical Allergen
Drug family (ATC) Local anesthetics, Anesthetics for topical use, Esters of aminobenzoic acid
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

LIGHTS Antiseptic and Pain Relieving Prep Pad is a topical solution containing isopropyl alcohol, benzocaine, and menthol. Isopropyl alcohol functions as an antiseptic to help clean and disinfect skin before medical procedures or injections. Benzocaine is a local anesthetic commonly used to numb the skin surface and reduce pain on contact, while menthol typically provides a cooling sensation. This product is marketed as an over-the-counter monograph drug under FDA guidelines for its category.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
61333-0222-02 You're viewing this Main listing 100 POUCH in 1 BOX / 1 PATCH in 1 POUCH / .35 mL in 1 PATCH 2026-08-07 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
LIGHTS Antiseptic and Pain Relieving Prep Pad 15 g/100mL; 1 g/100mL; 71 g/100mLthis 61333-0222-02 Lights 100 patches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Aug 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 5LKW3C543X
    A synthetic oily liquid derived from neopentyl glycol and heptanoic acid. It serves as an emollient and solvent in formulations, helping to dissolve or suspend active ingredients and improve the texture and spreadability of topical products.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesNeopentyl Glycol Diheptanoate, Neopentyl Glycol Diheptanoate Isododecane, Purified Water, 

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerLights Medical Manufacture Co., Ltd.
FDA applicationM003 (OTC MONOGRAPH DRUG)
Labeler code61333
First marketedAug 2026
Product typeHuman Otc Drug
Portfolio19 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 30 words ▾

Uses For the temporary relief of pain associated with needle sticks, minor burns, sunburns, minor cut, scrapes, minor skin irritations, and insect bites. Reduces the risk of infection. Kills germs.

⏱️ Dosage and Administration 60 words ▾

Directions Adults and children 2 yeas of age or older: Apply to affected area. Do not more than 4 times daily. Apply pad solution to the skin and gently rub in and let dry Test for effect by touching area before performing procedure May need to reapply for certain skin types Children under 2 yeas of age: Consult a doctor

⚠️ Warnings 13 words ▾

Warnings For external use only. Flammable, keep away from heat or open flame.

📦 Storage and Handling 6 words ▾

Other Information Protect from excessive heat

🧪 Active Ingredient 9 words ▾

Active Ingredient Isopropyl Alcohol: 71% Benzocaine 15% Menthol 1%

🧪 Inactive Ingredients 11 words ▾

Inactive Ingredient Neopentyl Glycol Diheptanoate, Neopentyl Glycol Diheptanoate Isododecane, Purified Water,

🎯 Purpose 6 words ▾

Purpose Antiseptic Topical Anesthetic Topical Anesthetic

📄 Do Not Use 27 words ▾

Do not use: Avoid contact with eyes, mouth, or mucous membranes. In case of contact with eyes, mouth, or mucous membranes, fush with water, call a doctor.

📄 When Using This Product 46 words ▾

When using this product, use glove with application had, or always wash the application hand immediately after application. Discontinue use if irritation occurs. If condition worsens or persists for more than 7 days, or clear up and occur again within a few days, consult a physician

📄 Keep Out of Reach of Children 16 words ▾

Keep out of reach of children. If swallowed, call a doctor or a Poison Control Center

📄 Package Label / Principal Display Panel 2 words ▾

image description

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for LIGHTS Antiseptic and Pain Relieving Prep Pad (this brand).

Top reported reactions

Pemphigus1,529
Glossodynia1,527
Hand Deformity1,508
Joint Swelling1,506
Helicobacter Infection1,501
Infusion Related Reaction1,494
Systemic Lupus Erythematosus1,490

Age at onset

Neonate24
Adolescent1
Adult604
Elderly23

Reporter sex

3,540 reports
Male · 2%
Female · 98%
Unknown · 0%

Serious outcomes

Disabling2,639
Life-threatening2,465
Hospitalization2,411
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1,319 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Lights Medical Manufacture Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Lights Medical Manufacture Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.